Executive team at A2 Milk sells shares

• Members of the executive leadership team at A2 Milk sold company shares following the vesting of performance rights.
• The equity transactions coincided with challenging operational conditions after the firm lost nearly two-thirds of its Chinese-label customer base.
• Management executed the stock sales under an established long-term incentive policy to cover personal tax obligations.

The A2 Milk Company (ASX:A2M) revealed that members of its executive team sold portions of their equity holdings following the recent vesting of performance rights.

The share sales followed a recent operational report indicating the business lost nearly two-thirds of its customer base in the Chinese-label segment due to supply chain disruptions.

"The a2 Milk company advises that, consistent with the approach in 2025 and the previously communicated view of the company’s board, members of its executive leadership team have sold shares equivalent to up to 50 per cent of the a2M shares received following the vesting of FY24 performance rights issued under the company’s long-term incentive plan," said A2 Milk Chair Pip Greenwood.

CEO David Landt Bortolussi sold nearly NZ$2 million worth of shares, while China CEO Xiao Li disposed of nearly NZ$1.5 million in equity.

The transactions were executed via broker facilities primarily to fund tax obligations associated with the long-term incentive programme.

Following the announcement, the A2 Milk share price was down at $6.86.

The infant formula producer continues working to rebuild its market presence in China while navigating a slow start to the current financial year.